News from magnolia medical technologies A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 11, 2020, 13:15 ET Magnolia Medical Appoints Renowned Clinical Microbiologist Gary V. Doern to Its Medical & Scientific Advisory Board

Magnolia Medical Technologies, Inc. today announced the appointment of Gary V. Doern, Ph.D., Professor Emeritus of Pathology, University of Iowa...


Oct 27, 2020, 13:15 ET Stanford Health Care Study Reports Zero Blood Culture Contaminations and False-Positive CLABSIs Using Steripath Gen2 ISDD

Magnolia Medical Technologies, Inc., inventors of Steripath®, the trusted solution for reducing blood culture contamination – today announced...


Oct 15, 2020, 13:15 ET Magnolia Medical Launches New Steripath® Micro Initial Specimen Diversion Device®

Magnolia Medical Technologies, Inc. – the trusted solution for reducing blood culture contamination – today announced the launch of its new...


Sep 23, 2020, 13:15 ET Magnolia Medical Awarded Innovative Technology Supplier of the Year by Vizient Inc.

Magnolia Medical Technologies, Inc. today announced that the company was selected as the Innovative Technology Supplier of the Year by Vizient Inc....


Sep 17, 2020, 13:15 ET Magnolia Medical Appoints Former Becton Dickinson Senior Executives to Its Medical & Scientific Advisory Board

Magnolia Medical Technologies, Inc. today announced the appointment of two healthcare safety veterans to its Medical & Scientific Advisory Board...


Sep 01, 2020, 13:15 ET Magnolia Medical Launches Mission to ZERO™ Aimed at Resetting the National Blood Culture Contamination Benchmark

Magnolia Medical Technologies, Inc. today announced the launch of Mission to ZERO, a nationwide initiative to create greater awareness of the patient ...


Jul 29, 2020, 13:15 ET Magnolia Medical Awarded Agreement with Intalere for Steripath Gen2 Initial Specimen Diversion Device

Magnolia Medical announced today that it has been awarded a 3-year agreement with Intalere for the Steripath® Gen2 Initial Specimen Diversion Device® ...


Jul 23, 2020, 13:46 ET Magnolia Medical Prevails with Summary Judgment for Baseless Lawsuit Filed by Kurin, Inc.

Magnolia Medical Technologies, Inc. ("Magnolia") announced today that the US District Court for the Southern District of California ruled on summary...


Jul 08, 2020, 13:15 ET Magnolia Medical Launches New Steripath Gen2 with Integrated Syringe

Magnolia Medical announced today the launch of the new Steripath® Gen2 Initial Specimen Diversion Device® with integrated syringe. The trusted...


May 13, 2020, 13:13 ET Newsweek Selects Steripath as a Best Infection Prevention Product of 2020

Magnolia Medical announced today that Newsweek®, in partnership with The Leapfrog Group, an independent nonprofit organization that evaluates health...


Mar 18, 2020, 09:00 ET Magnolia Medical Partners with Hospitals to Mitigate Critical Constraints Driven by COVID-19

Magnolia Medical announced today its pledge to partner with hospitals nationwide to address critical constraints associated with COVID-19. As part of ...


Mar 05, 2020, 09:00 ET Magnolia Medical Receives FDA 510K Clearance for Expanded Steripath Gen2 Product Family

Magnolia Medical today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of new configurations and the entire Steripath® Gen2...


Jan 23, 2020, 09:00 ET Consensus Publication Supports Magnolia Medical's Sepsis Testing Standard of Care Initiative

A peer-reviewed multi-disciplinary consensus manuscript published in the January edition of Clinical Microbiology Reviews (CMR) concluded that the...


Nov 14, 2019, 10:00 ET Magnolia Medical Announces Partnership with Cardinal Health

Magnolia Medical Technologies announced today a collaboration with Cardinal Health focused on improving clinical and economic outcomes by reducing...


Sep 30, 2019, 12:30 ET Steripath Study Awarded ENA 2019 Best Evidence-Based Project

An Inova Fairfax initiative measuring the impact of the Steripath® Gen2 Initial Specimen Diversion Device® (ISDD®) to reduce blood culture...


May 15, 2019, 07:00 ET Magnolia Medical and The Center for Phlebotomy Education Expand Continuing Education Program

Magnolia Medical Technologies and The Center for Phlebotomy Education announced the expansion of their training and education partnership dedicated...


Apr 17, 2019, 07:00 ET Reducing False Positive Results for Sepsis with Steripath Improves Economic and Clinical Outcomes, Study Reports

In the latest peer-reviewed published study on the impact of decreasing blood culture contamination rates using Steripath® ISDD®, researchers at...


Mar 11, 2019, 09:21 ET Magnolia Medical Protects its Innovative Technology from Patent Infringement

Magnolia Medical Technologies has asserted four patents in a patent infringement action against Kurin, Inc., asking a Federal court to enforce and...


Feb 14, 2019, 08:15 ET Magnolia Medical Appoints Matthew Lehr as Intellectual Property Special Counsel

Magnolia Medical Technologies today announced that Matthew B. Lehr has been named Intellectual Property Special Counsel and will advise the company...


Jan 30, 2019, 08:15 ET Magnolia Medical Announces $20 Million Series C Financing

Magnolia Medical Technologies today announced a $20 million Series C financing round to scale the company's infrastructure and market initiatives to...


Oct 17, 2018, 09:00 ET Magnolia Medical and The Center for Phlebotomy Education Announce Training and Education Partnership

Magnolia Medical Technologies, Inc. and The Center for Phlebotomy Education announced a collaborative training and education partnership dedicated to ...


Oct 03, 2018, 09:05 ET Magnolia Medical Launches Steripath Gen2 Best Practice Blood Culture Kit With Financially-Backed Clinical Performance Guarantee

Magnolia Medical Technologies, Inc. announced it is launching its new Best Practice Blood Culture Kit today at IDWeek 2018, in San Francisco,...


Sep 20, 2018, 09:00 ET Magnolia Medical Receives Innovative Technology Contract from Vizient, Inc. for Steripath Gen2 Initial Specimen Diversion Device

Magnolia Medical Technologies, Inc. announced today that it has been awarded an Innovative Technology contract with Vizient, Inc., the largest...


Aug 30, 2018, 08:09 ET Steripath Gen2, Next Generation Initial Specimen Diversion Device, Offers An Advanced Approach to Virtually Eliminating Blood Culture Contamination

Magnolia Medical Technologies today announced the successful national launch and adoption of Steripath® Gen2. The next generation Initial Specimen...


Aug 16, 2018, 08:12 ET Magnolia Medical Countersues Kurin for False and Misleading Advertising and Unfair Competition

Magnolia Medical Technologies announced today it has sued Kurin Inc. for false and misleading advertising and promotion of its Kurin Lock product,...